Viking Therapeutics Advances Pipeline with New Clinical Trial Launch
Shares rise as biotech firm begins Phase 1 study of experimental therapy VK3019 Shares of Viking Therapeutics (VKTX) moved higher ...
Tag: VKTX
Viking Therapeutics Accelerates Obesity Drug Pipeline with Phase 3 Momentum
VK2735 advances across injectable and oral formats as company strengthens position in weight-loss therapeutics Viking Therapeutics (VKTX) reported strong first-quarter ...
Viking Therapeutics: A High-Stakes Year in the Obesity Drug Race
Late-stage pipeline progress and market momentum position the biotech as a key emerging player Viking Therapeutics (VKTX) is entering a ...
Viking Therapeutics Moves Oral Obesity Drug Into Late-Stage Development
Company advances VKTX program as competition intensifies in the rapidly expanding weight-loss market Viking Therapeutics (VKTX) announced Wednesday that it ...
Viking Therapeutics Shares Plunge After High Dropout Rate in Weight-Loss Pill Trial
Strong weight reduction overshadowed by concerns over side effects Viking Therapeutics (VKTX) shares plummeted nearly 45% on Tuesday after the ...
